ABSI vs REGN: Which Stock is Better?
Side-by-side comparison of Absci Corp and Regeneron Pharmaceuticals Inc in 2026
ABSI
Absci Corp
—
REGN
Regeneron Pharmaceuticals Inc
$654.27
Key Metrics Comparison
| Metric | ABSI | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.13B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABSI
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABSI or REGN a better investment?
Comparing ABSI and REGN: Absci Corp has a market cap of $1.13B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABSI and REGN?
ABSI (Absci Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABSI or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABSI or REGN?
Both ABSI and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABSI or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABSI or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $1.13B for ABSI.
Should I buy ABSI or REGN in 2026?
Both ABSI and REGN have investment merit. ABSI trades at $N/A while REGN trades at $654.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABSI and REGN stock?
Key differences: Market Cap ($1.13B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABSI or REGN in 2026?
The choice between ABSI and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABSI and REGN?
ABSI (Absci Corp) has a market cap of $1.13B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.